{"id":11,"date":"2025-07-12T07:58:29","date_gmt":"2025-07-12T07:58:29","guid":{"rendered":"https:\/\/cninmed.com\/en\/?p=11"},"modified":"2025-07-30T14:15:04","modified_gmt":"2025-07-30T14:15:04","slug":"chinese-conpany-linces-out-bd-case","status":"publish","type":"post","link":"https:\/\/cninmed.com\/en\/2025\/11.html","title":{"rendered":"[China BD Deal] 3SBio and Pfizer Completes a 6 billion License on PD-1\/VEGF BsAbs SSGJ-707"},"content":{"rendered":"\n<p>Announced Date: 2025-05-19 (May 19, 2025),  2025-07-24 updated<\/p>\n\n\n\n<p>Asset Name: SSGJ-707<\/p>\n\n\n\n<p>Licensor: 3SBio, Inc\u00a0(01530.HK) (Headquarter Shanghai City, China)<\/p>\n\n\n\n<p>Licensee (Buyer): Pfizer Inc<\/p>\n\n\n\n<p>Asset Target: Bispecific antibody targeting PD-1 and VEGF<\/p>\n\n\n\n<p>Asset Modality: BsAbs <\/p>\n\n\n\n<p>Current Stage: China phase 2\u00a0;<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p>Scope of Authority:<\/p>\n\n\n\n<p>2025-05-19, exclusive global license to develop, manufacture and commercialize SSGJ-707 worldwide, excluding China.  The option of commercialization rights in China.<\/p>\n\n\n\n<p>2025-07-24, add exclusive rights in China.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p>Deal Detail:<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p>Upfront payment of\u00a0$1.25 billion, (add 150 million)<\/p>\n\n\n\n<p>Milestone payments up to \u00a0$4.8 billion <\/p>\n\n\n\n<p>Royalties on net sales, tiered double-digit<\/p>\n\n\n\n<p>Total 6.1 billion plus<\/p>\n\n\n\n<p>Pfizer will also make a $100 million equity investment in 3SBio.\u00a0<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p>Link:<\/p>\n\n\n\n<p>Pfizer Completes Licensing Agreement with 3SBio<\/p>\n\n\n\n<p><a href=\"https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer-completes-licensing-agreement-3sbio\">https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer-completes-licensing-agreement-3sbio<\/a><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p>Pfizer Enters into Exclusive Licensing Agreement with 3SBio<\/p>\n\n\n\n<p><a href=\"https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer-enters-exclusive-licensing-agreement-3sbio\">https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer-enters-exclusive-licensing-agreement-3sbio<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Announced Date: 2025-05-19 (May 19, 2025), 2025-07-24 updated Asset Name: SSGJ-707 Licensor: 3SBio, Inc\u00a0(01530.HK) (Headquarter Shanghai &hellip; <a title=\"[China BD Deal] 3SBio and Pfizer Completes a 6 billion License on PD-1\/VEGF BsAbs SSGJ-707\" class=\"hm-read-more\" href=\"https:\/\/cninmed.com\/en\/2025\/11.html\"><span class=\"screen-reader-text\">[China BD Deal] 3SBio and Pfizer Completes a 6 billion License on PD-1\/VEGF BsAbs SSGJ-707<\/span>Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-11","post","type-post","status-publish","format-standard","hentry","category-china-license-out"],"_links":{"self":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts\/11","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/comments?post=11"}],"version-history":[{"count":10,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts\/11\/revisions"}],"predecessor-version":[{"id":47,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts\/11\/revisions\/47"}],"wp:attachment":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/media?parent=11"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/categories?post=11"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/tags?post=11"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}